CN108837007A - The liquid medicine and preparation method thereof for treating fracture - Google Patents
The liquid medicine and preparation method thereof for treating fracture Download PDFInfo
- Publication number
- CN108837007A CN108837007A CN201811037009.4A CN201811037009A CN108837007A CN 108837007 A CN108837007 A CN 108837007A CN 201811037009 A CN201811037009 A CN 201811037009A CN 108837007 A CN108837007 A CN 108837007A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- liquid medicine
- white wine
- profound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of liquid medicine and preparation method thereof for treating fracture, the composition and quality proportioning of the bulk pharmaceutical chemicals of liquid medicine are as follows:25~32 parts of Radix Astragali, 25~32 parts of Radix Codonopsis, 25~32 parts of Radix Notoginseng, 25~32 parts of safflower, 25~32 parts of profound Hu, 25~32 parts of Rhizoma Chuanxiong, 15~19 parts of Caulis Spatholobi, 8-12 parts of radix cyathulae, 20~30 parts of Radix Angelicae Sinensis, 15~20 parts of olibanum, 15~20 parts of myrrh, 15~20 parts of radix dipsaci, 15~20 parts of radix paeoniae rubra, 15~20 parts of Radix Salviae Miltiorrhizae, 1000-1500 parts of white wine of 50 °~65 °.The step of preparation method is:A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 2-5mm thickness, then Radix Notoginseng and profound Hu broken into medicinal powder, finally tablet and medicinal powder are mixed, obtain mixture;B, it impregnates:Fill this blend into the white wine of the proportion, sealing, impregnate 2 years to get.The therapeutic effect of the liquid medicine is good, and toxic side effect is small.
Description
Technical field
The present invention relates to a kind of liquid medicine for treating fracture.
Background technique
Fracture is a kind of common injury.It mostly occurs in, old age, also has many young man's exogenous injuries, crushes
Property fracture.After the reduction of the fracture, clinic belongs to Chinese medicine bi Zheng (heumatism) model characterized by arthroncus, pain, stiff, limitation of activity
Farmland.If treatment is not in time, restore slow, directly affect quality of life of patients.
Currently, based on drug therapy after the reduction of the fracture mainly shares with analgesic, anti-inflammatory drug.Also oral administration Chinese medicine, mesh
Be to eliminate swelling, mitigation and alleviate pain symptom etc..But oral medicine need by digestive system, liver, kidney metabolism after again to bone
The generation effect of folding part position, side effect is big, and the utilization rate of drug is low, and curative effect is to be improved.
Summary of the invention
The purpose of the present invention is to provide a kind of liquid medicine for treating fracture, which is used for the treatment after the reduction of the fracture.Its
Therapeutic effect is good, and toxic side effect is small, easy to use, and treatment cost is low.
The technical scheme adopted by the invention for realizing the object of the invention is a kind of liquid medicine for treating fracture, bulk pharmaceutical chemicals
Composition and quality proportioning are as follows:
25~32 parts of Radix Astragali, 25~32 parts of Radix Codonopsis, 25~32 parts of Radix Notoginseng, 25~32 parts of safflower, 25~32 parts of profound Hu, Rhizoma Chuanxiong
25~32 parts, 15~19 parts of Caulis Spatholobi, 8-12 parts of radix cyathulae, 20~30 parts of Radix Angelicae Sinensis, 15~20 parts of olibanum, 15~20 parts of myrrh,
15~20 parts of radix dipsaci, 15~20 parts of radix paeoniae rubra, 15~20 parts of Radix Salviae Miltiorrhizae, 1000-1500 parts of white wine of 50 °~65 °.
Further, the quality proportioning of currently preferred bulk pharmaceutical chemicals is:
26 parts of Radix Astragali, 26 parts of Radix Codonopsis, 26 parts of Radix Notoginseng, 26 parts of safflower, 26 parts of profound Hu, 26 parts of Rhizoma Chuanxiong, 16 parts of Caulis Spatholobi, river ox
10 parts of knee, 20 parts of Radix Angelicae Sinensis, 16 parts of olibanum, 16 parts of myrrh, 16 parts of radix dipsaci, 16 parts of radix paeoniae rubra, 16 parts of Radix Salviae Miltiorrhizae, 50 °~65 ° of white wine
1300 parts.
The above-mentioned method for treating the liquid medicine fractured is prepared another object of the present invention is to provide a kind of, this method
Preparation manipulation is simple, and preparation cost is low.
The present invention realizes its another goal of the invention the technical scheme adopted is that a kind of medicine for preparing above-mentioned treatment fracture
The method of wine, step are:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 2-5mm thickness, then by Radix Notoginseng tablet and
Profound Hu tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
The application method of liquid medicine of the invention is:
A, so that cotton is drenched on the cotton in liquid medicine, then cotton is placed on outside the bandage that fracture splint wrapping fixes
Face;Then cotton is wrapped up with plastic cloth, to reduce liquid medicine evaporation rate;
B, after 4 hours, plastic cloth is opened, drenched cotton or replacement new cotton again with liquid medicine, and liquid medicine is poured on cotton
Taking keeps cotton drenched;Finally, cotton is placed on outside the bandage that fracture splint wrapping fixes again;And with plastic cloth binding cotton
Flower.
C, the operation of b step is repeated, until swelling, pain symptom are eliminated.
Liquid medicine of the invention, the pharmacological action that treatment is fractured are:
Alcohol in white wine can sufficiently dissolve effective ingredient in liquid medicine in immersion in 2 years, and when use is dissolved in
Effective ingredient in alcohol can penetrate into fracture site, and have an effect in fracture site.
Monarch drug in a prescription in drug:Safflower, radix dipsaci, Radix Notoginseng, myrrh, radix paeoniae rubra, profound Hu, Radix Salviae Miltiorrhizae all have function of promoting blood circulation to disperse blood clots, red
Flower also has effect for reducing blood fat, antihypertensive effect, anti-inflammatory effect;Radix Notoginseng, myrrh, radix paeoniae rubra, profound Hu, Radix Salviae Miltiorrhizae, with detumescence ding-tong
Function;Radix dipsaci has the function of strengthening the bones and muscles, reunion of fractured tendons and bones;Ministerial drug in drug:Olibanum has the function of myogenic pain relieving;In drug
Make medicine:Caulis Spatholobi has the function of promoting blood circulation, relaxing muscles and tendons, and Radix Angelicae Sinensis has the function of replenishing and activating blood;Adjutant radix cyathulae tool in drug
There is the effect of dampness removing promoting menstruation, promoting blood circulation.In the activating microcirculation and removing stasis medicinal of these drugs, anti-inflammatory, detumescence ding-tong, strengthening the bones and muscles, reunion of fractured tendons and bones, myogenic
Under the mutually promoting, act synergistically of analgesic efficacy, the tissue of fracture site, function are preferably restored, swelling, pain
Symptom obtains significantly mitigating, alleviate, significant in efficacy.
Compared with prior art, the beneficial effects of the invention are as follows:
One, ten four traditional Chinese medicine objects in liquid medicine of the present invention mutually promote, act synergistically, and generate activating microcirculation and removing stasis medicinal, anti-inflammatory, detumescence is determined
Bitterly, the effect of strengthening the bones and muscles, reunion of fractured tendons and bones, myogenic pain relieving, the tissue of fracture site, function can be made preferably to be restored, swollen
Swollen, pain symptom obtains significantly mitigating, alleviate, good effect.Clinical test shows that it is efficient up to 85%.
Two, the drug ingedient in liquid medicine of the invention can quickly penetrate into fracture site, directly occur in fracture site
Effect.Compared with the oral administration medicament for needing to absorb, convert by alimentary canal, liquid medicine of the invention had both improved the utilization of effective component
Rate and curative effect;Meanwhile also reducing the toxic side effect of drug.
Alcohol in white wine can sufficiently dissolve effective ingredient in liquid medicine in immersion in 2 years, also improve drug
The utilization rate of ingredient;In use, alcohol, which also contributes to effective ingredient, can penetrate into fracture site, medicine is further improved
The utilization rate of object ingredient.
Three, bulk pharmaceutical chemicals need to be only sliced or be smashed by the present invention, add soaking in Chinese liquor to obtain the final product, and preparation manipulation is simple, system
It is standby at low cost.
The present invention is described in further detail With reference to embodiment.
Specific embodiment
Embodiment 1
A kind of liquid medicine for treating fracture, the composition and quality proportioning of bulk pharmaceutical chemicals are as follows:
26 parts of Radix Astragali, 26 parts of Radix Codonopsis, 26 parts of Radix Notoginseng, 26 parts of safflower, 26 parts of profound Hu, 26 parts of Rhizoma Chuanxiong, 16 parts of Caulis Spatholobi, river ox
10 parts of knee, 20 parts of Radix Angelicae Sinensis, 16 parts of olibanum, 16 parts of myrrh, 16 parts of radix dipsaci, 16 parts of radix paeoniae rubra, 16 parts of Radix Salviae Miltiorrhizae, 1300 parts of white wine of 50 °.
A method of the liquid medicine of above-mentioned treatment fracture being prepared, step is:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 2mm thickness, then by Radix Notoginseng tablet and profound
Hu tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
Clinical test:With the liquid medicine of the present embodiment 1, fracture patient 90 after the reduction of the fracture are carried out treatment phase 30 days
Clinical Treatment Test.Test proves, after treatment 30 days, the rate that completely disappears of swelling, pain symptom after the reduction of the fracture is 70%,
Symptom mitigation rate is 29%, shows that it is efficient up to 99%.
Embodiment 2
A kind of liquid medicine for treating fracture, the composition and quality proportioning of bulk pharmaceutical chemicals are as follows:
25 parts of Radix Astragali, 25 parts of Radix Codonopsis, 25 parts of Radix Notoginseng, 25 parts of safflower, 25 parts of profound Hu, 25 parts of Rhizoma Chuanxiong, 19 parts of Caulis Spatholobi, river ox
12 parts of knee, 30 parts of Radix Angelicae Sinensis, 20 parts of olibanum, 20 parts of myrrh, 20 parts of radix dipsaci, 20 parts of radix paeoniae rubra, 20 parts of Radix Salviae Miltiorrhizae, 1000 parts of white wine of 55 °.
A method of the liquid medicine of above-mentioned treatment fracture being prepared, step is:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 3mm thickness, then by Radix Notoginseng tablet and profound
Hu tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
Embodiment 3
A kind of liquid medicine for treating fracture, the composition and quality proportioning of bulk pharmaceutical chemicals are as follows:
32 parts of Radix Astragali, 32 parts of Radix Codonopsis, 32 parts of Radix Notoginseng, 32 parts of safflower, 2 parts of profound Hu, 32 parts of Rhizoma Chuanxiong, 15 parts of Caulis Spatholobi, river ox
8 parts of knee, 20 parts of Radix Angelicae Sinensis, 15 parts of olibanum, 15 parts of myrrh, 15 parts of radix dipsaci, 15 parts of radix paeoniae rubra, 15 parts of Radix Salviae Miltiorrhizae, 1500 parts of white wine of 60 °.
A method of the liquid medicine of above-mentioned treatment fracture being prepared, step is:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 2-5mm thickness, then by Radix Notoginseng tablet and
Profound Hu tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
Embodiment 4
A kind of liquid medicine for treating fracture, the composition and quality proportioning of bulk pharmaceutical chemicals are as follows:
28 parts of Radix Astragali, 29 parts of Radix Codonopsis, 27 parts of Radix Notoginseng, 28 parts of safflower, 29 parts of profound Hu, 28 parts of Rhizoma Chuanxiong, 17 parts of Caulis Spatholobi, river ox
11 parts of knee, 25 parts of Radix Angelicae Sinensis, 18 parts of olibanum, 18 parts of myrrh, 18 parts of radix dipsaci, 17 parts of radix paeoniae rubra, 18 parts of Radix Salviae Miltiorrhizae, 1200 parts of white wine of 65 °.
A method of the liquid medicine of above-mentioned treatment fracture being prepared, step is:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 5mm thickness, then by Radix Notoginseng tablet and profound
Hu tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
Claims (3)
1. a kind of liquid medicine for treating fracture, the composition and quality proportioning of bulk pharmaceutical chemicals are as follows:
25~32 parts of Radix Astragali, 25~32 parts of Radix Codonopsis, 25~32 parts of Radix Notoginseng, 25~32 parts of safflower, 25~32 parts of profound Hu, Rhizoma Chuanxiong 25~
32 parts, 15~19 parts of Caulis Spatholobi, 8-12 parts of radix cyathulae, 20~30 parts of Radix Angelicae Sinensis, 15~20 parts of olibanum, 15~20 parts of myrrh, radix dipsaci
15~20 parts, 15~20 parts of radix paeoniae rubra, 15~20 parts of Radix Salviae Miltiorrhizae, 1000-1500 parts of white wine of 50 °~65 °.
2. a kind of liquid medicine for treating fracture according to claim 1, which is characterized in that the quality proportioning of the bulk pharmaceutical chemicals
For:
26 parts of Radix Astragali, 26 parts of Radix Codonopsis, 26 parts of Radix Notoginseng, 26 parts of safflower, 26 parts of profound Hu, 26 parts of Rhizoma Chuanxiong, 16 parts of Caulis Spatholobi, radix cyathulae 10
Part, 20 parts of Radix Angelicae Sinensis, 16 parts of olibanum, 16 parts of myrrh, 16 parts of radix dipsaci, 16 parts of radix paeoniae rubra, 16 parts of Radix Salviae Miltiorrhizae, 50 °~65 ° of white wine 1300
Part.
3. a kind of method for the liquid medicine for preparing treatment fracture of any of claims 1 or 2, step are:
A, it prepares:By the proportion, the bulk pharmaceutical chemicals in addition to white wine be cut into the tablet of 2-5mm thickness, then by Radix Notoginseng tablet and profound Hu
Tablet breaks into medicinal powder, finally mixes all tablets and medicinal powder, obtains solid mixt;
B, it impregnates:By A walk solid mixt be fitted into the white wine of the proportion, sealing, impregnate 2 years to get.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811037009.4A CN108837007A (en) | 2018-09-06 | 2018-09-06 | The liquid medicine and preparation method thereof for treating fracture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811037009.4A CN108837007A (en) | 2018-09-06 | 2018-09-06 | The liquid medicine and preparation method thereof for treating fracture |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108837007A true CN108837007A (en) | 2018-11-20 |
Family
ID=64188763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811037009.4A Pending CN108837007A (en) | 2018-09-06 | 2018-09-06 | The liquid medicine and preparation method thereof for treating fracture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108837007A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110240994A (en) * | 2019-07-25 | 2019-09-17 | 文山郑保骨伤科医院 | A kind of bone fracture liquid medicine suitable for the fracture recovering phase |
-
2018
- 2018-09-06 CN CN201811037009.4A patent/CN108837007A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110240994A (en) * | 2019-07-25 | 2019-09-17 | 文山郑保骨伤科医院 | A kind of bone fracture liquid medicine suitable for the fracture recovering phase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101214286A (en) | Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases | |
CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
CN101032616A (en) | Chinese medicinal herb composition for external use for quickly recovering muscle and ligament and the preparing method | |
CN101524450B (en) | Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof | |
CN102228586A (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
CN103446528B (en) | Chinese medicinal composition used for stopping pain and reducing swelling and preparation thereof | |
CN102225109B (en) | Quick-acting fracture setting medicine powder | |
CN104383434A (en) | Externally applied medicament for treating traumatic injuries and rheumatism and preparation method of externally applied medicament | |
CN108837007A (en) | The liquid medicine and preparation method thereof for treating fracture | |
CN100411661C (en) | Amber bolus | |
CN104706749B (en) | A kind of Chinese medicine composition for treating lumbar vertebrae shoulder disc protrusion | |
CN105770847A (en) | Traditional Chinese medicine composition for relieving or treating joint swelling and pain and preparation method and application of traditional Chinese medicine composition | |
CN105617198A (en) | Method for preparing medicinal liquor for treating wind-cold low back pain | |
CN105535380A (en) | Medicine bathing bag and preparing method thereof | |
CN101342287A (en) | Medical ointment for quickly knitting bone, relaxing tendons, and activating blood circulation, removing stasis, and preparation method thereof | |
CN1069833C (en) | Hand liniment | |
CN100486640C (en) | Externally applied medicine for treating neck and waist arthrosis | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN102697928B (en) | Preparation method for medicine composition for treating traumatic injury | |
CN106540026A (en) | A kind of medicated pillow and its filler formulation for treating cervical spondylosiss and scapulohumeral periarthritis | |
CN101642496A (en) | Chinese medicinal preparation for treating bone injury diseases | |
CN1298717A (en) | Process for preparing Tibetan medicines | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
CN105943781A (en) | Method for preparing orthopedic plaster | |
CN106421255A (en) | Topical traditional Chinese composition and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181120 |
|
RJ01 | Rejection of invention patent application after publication |